| P2093 | author name string | Yung Hyun Choi | |
| | Gi-Young Kim | |
| | Rajapaksha Gedara Prasad | |
| P2860 | cites work | Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. | Q44240436 |
| | NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program | Q24815705 |
| | Anticancer agent shikonin is an incompetent inducer of cancer drug resistance | Q28484828 |
| | An oxidative stress mechanism of shikonin in human glioma cells | Q28537574 |
| | Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 |
| | Nitric oxide and macrophage function | Q29615327 |
| | Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism | Q29615446 |
| | Nitric oxide synthases: Roles, tolls, and controls | Q29618629 |
| | Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging | Q30557279 |
| | Microglia as mediators of inflammatory and degenerative diseases | Q33593415 |
| | The clinical potential of cyclooxygenase-2-specific inhibitors | Q33676740 |
| | Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity | Q33957447 |
| | Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation | Q34338138 |
| | Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma | Q34442308 |
| | Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals | Q34583278 |
| | The inflammatory macrophage: a story of Jekyll and Hyde | Q35041589 |
| | Inhibition of lipopolysaccharide‐inducible nitric oxide synthase, TNF‐α and COX‐2 expression by sauchinone effects on I‐κBα phosphorylation, C/EBP and AP‐1 activation | Q35045262 |
| | Topoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells | Q35058674 |
| | NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. | Q35735669 |
| | Nitric oxide in neurodegenerative diseases | Q35969171 |
| | NF-kappa B as a therapeutic target in neurodegenerative diseases | Q36709527 |
| | Therapeutic targets in prostaglandin E2 signaling for neurologic disease. | Q37221356 |
| | Anti-TNF-α Agents in the Treatment of Immune-Mediated Inflammatory Diseases: Mechanisms of Action and Pitfalls | Q37810960 |
| | Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories | Q37959790 |
| | NF-κB signaling pathway and free radical impact. | Q38031467 |
| | Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages | Q38357227 |
| | Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway. | Q38981543 |
| | Curcumin induces the apoptotic intrinsic pathway via upregulation of reactive oxygen species and JNKs in H9c2 cardiac myoblasts | Q39011838 |
| | Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-κB signaling pathways | Q39032335 |
| | Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells. | Q39145005 |
| | Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation | Q39163550 |
| | Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance | Q39913286 |
| | Tumor necrosis factor: a pleiotropic cytokine and therapeutic target | Q40759728 |
| | Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase | Q40789302 |
| | Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK β Activity and JNK Phosphorylation | Q41428122 |
| | Curcumin attenuates oxidative stress following downhill running-induced muscle damage. | Q43464925 |
| | Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability | Q43537285 |
| | Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway | Q43732296 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | NF-κB | Q411114 |
| | lipopolysaccharide | Q421804 |
| | reactive oxygen species | Q424361 |
| | microglia | Q1622829 |
| | Lithospermum erythrorhizon | Q15592453 |
| P304 | page(s) | 110-118 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Biomolecules & therapeutics | Q20020559 |
| P1476 | title | Shikonin Isolated from Lithospermum erythrorhizon Downregulates Proinflammatory Mediators in Lipopolysaccharide-Stimulated BV2 Microglial Cells by Suppressing Crosstalk between Reactive Oxygen Species and NF-κB. | |
| P478 | volume | 23 | |